← Evidence map

ArticleHaematologica2024

Reply to the Comment on: "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry".

Tommaso Francesco Aiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Reply to the Comment on: "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry". | OpenQuestion